Supplementary Table S2 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Autoría

autor: Lajos Pusztai, Hope Rugo, Douglas Yee, Angela DeMichele, Sarah L Blair, Scott Berry, Nola M Hylton, Julie Lang, Amy Jo Chien, Rita Nanda, Tufia C Haddad, Debu Tripathy, Claudine Isaacs, Gillian L Hirst, Anthony D Elias, Gregor Krings, David M Euhus, William Symmans, Laura Esserman, Judy Boughey, Michelle E Melisko, Jane Perlmutter, Don Berry, Laura van 't Veer